Follow-up appointments are typically scheduled at 24 weeks, 36 months, and 1 year to monitor progress and symptom relief
This is usually temporary and not directly caused by the peptide itself
Groups that should avoid or seek clinician guidance first Pregnancy and breastfeeding: GHK-Cu has not been adequately studied in pregnancy or lactation
PMC 5573066
Type of study: Number of citations: 1 Year: 2025 Authors: Kehan Chen, Hui Yang, Guo Xu, Yunhan Hu, Xue Tian, Song Qin, Tianyue Jiang Journal: RSC medicinal chemistry Journal ranking: Q1 Key takeaways: The Cur-CNEs/Gel, an oligopeptide hydrogel encapsulating curcumin-loaded nanoemulsions, effectively enhances skin penetration and alleviates psoriasis symptoms in mice
Potential risks of using GHK-Cu peptide include topical irritation, allergic reaction, formulation sensitivity, incomplete long-term safety data, and route-specific concerns